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Convection does not govern plasma to dialysate transport of protein.
The dependence of protein clearance on molecular size during perito-
neal dialysis can be explained by assuming that either convection or
diffusion is the major mechanism governing plasma to dialysate trans-
port of protein. If convection is the predominant transport mechanism,
then plasma-to-dialysate transport rates for protein should not decrease
when the protein concentration in the instilled dialysis solution is
increased. In the present study, plasma-to-dialysate transport rates for
fluorescein-labeled protein tracers, n-lactalbumin and immunoglobulin
G (IgG), were determined during a six hour isotonic exchange (25 ml/kg)
in New Zealand White rabbits. The protein tracers were continuously
infused into the bloodstream to keep plasma concentrations relatively
constant, and transperitoneal transport rates were determined either
with or without tracer protein added to the instilled dialysis solution.
Plasma-to-dialysate transport rates were greater for a-lactalbumin than
for LgG as expected based on the molecular size of these proteins.
Transport rates for both a-lactalbumin and IgG decreased when tracer
protein was added to the instilled dialysis solution. The present obser-
vations do not support convection as the major mechanism governing
plasma to dialysate transport of protein during peritoneal dialysis.
Protein loss into the dialysis solution is a concern when using
continuous ambulatory peritoneal dialysis (CAPD) for chronic
maintenance dialysis therapy [1]. Total protein losses range
between 5 and 20 g per day [2, 3], and albumin accounts for
approximately half of the lost protein [3, 4]. Dialysate protein
concentrations increase linearly with dwell time and are con-
siderably less than plasma levels [5]. The major source of the
protein lost during CAPD is the vascular pool [61, although
nonvascular sources of protein may contribute to the total loss
rate [31.
Transport of proteins and other macromolecules between
plasma and the peritoneal cavity is asymmetric [7]. This asym-
metry results primarily because of one-way protein transport
out of the peritoneal cavity directly into adjacent tissues [81 or
by the lymphatics [9J. Protein transport via this pathway is by
convection since it depends solely on the protein concentration
in peritoneal fluid and the fluid absorption rate from the
peritoneal cavity [10, 11]. Proteins lost from the peritoneal
cavity by this convective pathway are unavailable for direct
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plasma to dialysate transport, since they are trapped either in
lymphatics or in the tissues surrounding the peritoneal cavity
[9, 12].
Rippe and Stelin [13] have argued that direct plasma to
dialysate transport of large proteins may also be asymmetric.
These workers have demonstrated that the dependence of
protein clearance on molecule size during CAPD can be ex-
plained by assuming that convection through large pores gov-
erns transperitoneal protein transport. Asymmetric convective
transport through large pores is theoretically possible across the
heteroporous peritoneal membrane even when using isotonic
dialysis solution, because plasma protein exerts little or no
counteracting oncotic pressure across the large pores. Based on
similar data, however, Krediet et al [14] have argued that
transperitoneal protein transport is governed by hindered diffu-
sion of proteins across the peritoneal membrane. It is not
possible to discriminate between these contrasting interpreta-
tions based upon available data.
Assuming the peritoneal membrane can be described as a
simple barrier separating plasma from dialysis solution in the
peritoneal cavity, it is possible to differentiate between diffusion
and convection by the dependence of transperitoneal protein
transport on protein concentration in plasma and dialysis solu-
tion. Diffusive protein transport across the peritoneal mem-
brane should be proportional to the concentration difference
between plasma and the peritoneal cavity, whereas convective
protein transport should be independent of the peritoneal dial-
ysis solution concentration. To determine whether diffusion or
convection is the major mechanism governing direct plasma to
dialy sate transport of protein, the present study determined the
dependence of transperitoneal transport on the protein concen-
tration in the instilled dialysis solution in a rabbit model of
peritoneal dialysis.
Methods
Protein tracers and solutions
Fluorescein isothiocyanate (FITC)-labeled rabbit immuno-
globulin G (IgG) was obtained from Sigma Chemical (Catalog
No. F 7256; St. Louis, Missouri, USA) and dialyzed at 4°C
against a 0.15 M NaCl solution for 24 hours using Spectralpor
tubing (12,000 to 14,000 molecular weight cutoff; Spectrum
Medical, Los Angeles, California, USA) before use. Bovine
o-lactalbumin was obtained from Sigma (Catalog No. L 6010)
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and labeled with the FITC analog 5-(4,6-dichlorotriazin-2-yl)-
amino fluorescein hydrochloride (DTAF; Eastman Kodak,
Rochester, New York, USA) by using previously published
methods [15]. The DTAF-labeled protein was separated from
the unreacted label by membrane dialysis at 4°C for at least 72
hours using Spectralpor tubing (3500 molecular wt cutoff;
Spectrum). These two proteins were chosen as tracers because
of the large difference in their molecular sizes; molecular
weights for IgG and c-lactalbumin are 153,000 [16] and 14,200
[17], respectively. The fluorescent properties of FITC, DTAF
and their labeled conjugates are virtually identical [15].
Normosol R solutions were obtained from Abbott Laborato-
ries (North Chicago, Illinois, USA). Normosol R solutions had
a pH of 6.8 and contained 140 mEq/liter sodium, 5 mEq/liter
potassium, 3 mEq/liter magnesium, 98 mEq/liter chloride, 27
mEq/liter acetate, and 23 mEq/liter gluconate. Isotonic dialysis
solutions were prepared by adding 5 g of glucose (EM Science,
Gibbstown, New Jersey, USA) to 1 liter of Normosol R.
Experimental
Male New Zealand White rabbits (2.7 to 3.7 kg in body wt)
were fasted overnight and anesthetized by an intramuscular
injection of acepromazine maleate (16 mg/kg) and xylazine HC1
(3 mg/kg), followed 10 minutes later by an intramuscular
injection of ketamine HC1 (50 mg/kg). A carotid artery and
jugular vein were cannulated for blood sampling and the infu-
sion of solutions, respectively. These cannulas were exterior-
ized and taped to the back of the neck to allow unrestricted
access to them during the experiment. A one-half inch incision
in the skin and in the first layer of muscle of the right lumbar
region was then made. The peritoneal cavity was penetrated
and a peritoneal catheter (Sil-Med Corporation, Taunton, Mas-
sachusetts, USA) inserted using a trocar. The peritoneal cath-
eter was secured with a purse-string suture. No additional
anesthetic was given after surgery was completed.
After obtaining a 2 ml baseline arterial blood sample, a
60-minute washout exchange of the peritoneal cavity using
Normosol R was performed (25 mI/kg). A priming dose of either
FITC-labeled IgG (5 mg) or DTAF-labeled a-lactalbumin (10
mg) was dissolved in 20 ml of Normosol R solution and infused
intravenously over a 10 minute period. This was followed by a
continuous intravenous infusion (0.4 ml/min) of Normosol R
solution containing the tracer protein to maintain relatively
constant plasma levels. After 60 minutes the peritoneal cavity
was drained by gravity, and the experiment was initiated.
Isotonic dialysis solution was prewarmed to 37°C and in-
stilled into the peritoneal cavity (25 mI/kg) immediately follow-
ing drainage of the washout exchange. In certain experiments
tracer protein was also added to the instilled isotonic dialysis
solution. A 3 ml dialysate sample was taken five minutes after
the dialysis solution was completely instilled and then hourly
over a six hour dwell. A 2 ml arterial blood sample was obtained
concomitantly with each dialysate collection. After the six hour
samples were taken, the peritoneal cavity was drained and 30
ml of isotonic dialysis solution containing 40 mg blue dextran
(average molecular weight of 2,000,000; Sigma) were instilled.
After five minutes, a sample of the resulting solution in the
peritoneal cavity was collected to calculate the residual volume
of dialysis solution remaining in the peritoneal cavity. The
experiment was terminated by a barbiturate overdose.
A total of 22 experiments were performed. The protocol for
each experiment was identical except for the tracer proteins
infused intravenously or added to the instilled isotonic dialysis
solution. Two control experiments were performed without any
tracer proteins added to either the bloodstream or the instilled
dialysis solution. Eight experiments were performed with
FITC-labeled IgG infused intravenously; four used dialysis
solution without added tracer protein and four used dialysis
solution containing FITC-labeled IgG. Twelve experiments
were performed with DTAF-labeled a-lactalbumin infused in-
travenously; four used dialysis solution without added tracer
protein, four used dialysis solution containing DTAF-labeled
a-lactalbumin, and four used dialysis solution containing FITC-
labeled IgG. The concentration of tracer protein added to the
dialysis solution in each experiment was such that the initial
fluorescence ranged between 25% and 50% of the average value
in plasma.
Analytical techniques
The concentration of tracer protein in plasma and dialysis
solution was determined using a fluorescence spectrophotome-
ter (Model F-4010: Hitachi Ltd., Tokyo, Japan). The excitation
wavelength of 490 nm and the emission wavelength of 525 nm
was identical for both FITC- and DTAF-labeled protein. Plasma
and dialysis solution were appropriately diluted (at least 1:1) in
a 0.05 M glycine buffer, pH 9.4, before fluorescence was
determined. Control experiments demonstrated that fluores-
cence was linearly proportional to both FITC-labeled IgG and
DTAF-labeled a-lactalbumin concentration; moreover, fluores-
cence was comparable in plasma and dialysis solution.
Certain plasma and dialysate samples were further analyzed
by high performance size exclusion (gel permeation) chroma-
tography using methods described previously [18]. Size exclu-
sion chromatography was performed using a TSK-G4000PW
column with a column buffer containing 1.0 M ammonium
acetate and 0.05 M sodium phosphate, pH 9.0. A Waters Model
420-E fluorescence detector was employed for monitoring
changes in fluorescence in the column effluent, with excitation
at 450 nm and emission at 500 nm. Each sample was injected
directly onto the column without further preparation.
The concentration of blue dextran was determined spectro-
photometrically at a wavelength of 620 nm (Model 300-N:
Gilford Instrument Laboratories, Oberlin, Ohio, USA). Hema-
tocrit was measured in all blood samples by centrifugation.
Calculations
The dependence of tracer protein concentration in the dialy-
sis solution on time is, in general, nonlinear and depends on the
initial volume of dialysis solution, the rate of fluid absorption
from the peritoneal cavity and the mechanism governing plasma
to dialysate transport. Equations describing the dependence of
tracer protein concentration in the dialysis solution on time
have been derived in the Appendix. Figure 1 plots the predicted
dialysate-to-plasma protein concentration ratio versus time for
two different initial protein concentrations in the dialysis solu-
tion under specified conditions, and assuming that either con-
vection or diffusion is the mechanism governing plasma to
dialysate transport. When the initial protein concentration in
the dialysis solution is zero, the concentration in dialysis
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Fig. 1. The predicted dialysate to plasma:protein concentration ratio
plotted as a function of dwell time for d/fusive (equation 6) and
convective (equation (7), assuming J,,S = P)protein transport. Symbols
are: (—) convective transport; (— — —) diffusive transport. Predictions
are shown for initial dialysate-to-plasma concentration ratios of 0 and
50%. The parameter values employed in these calculations were PA =
40 tl/min, V0 = 80ml, and L = 0.1 mI/mm. Additional details are in the
Appendix.
solution increases approximately linearly with time; these pre-
dictions are similar whether convection or diffusion is the
predominant transport mechanism. When the initial protein
concentration is increased to 50% of the plasma level, however,
the increase in the concentration in the dialysis solution de-
pends on the assumed transport mechanism.
Although the increase in concentration in the dialysis solution
with time is nonlinear, the degree of nonlinearity is not great.
Therefore, rates of plasma to dialysate protein transport were
expressed as clearance and were estimated by multiplying the
volume of dialysis solution by the slope of the dependence of
dialysate to plasma tracer protein concentration ratio on dwell
time between two and six hours. When clearance values were
calculated using data from between zero and six hours or
between one and six hours, all clearance values were lower than
those reported. In each calculation the values of plasma con-
centration and dialysate volume employed were the arithmetic
mean throughout the six hour dwell.
The residual volume of dialysis solution remaining in the
peritoneal cavity after gravity drainage was determined from
the decrease in blue dextran concentration after instillation of
blue dextran containing solution into the peritoneal cavity at the
end of the exchange. The final true volume of dialysis solution
remaining in the peritoneal cavity at the end of the exchange
was therefore assumed to be the sum of the volume drained and
the calculated residual volume. Assuming the residual volume
is the same in both the washout and experimental exchanges,
the fluid absorption rate from the peritoneal cavity was calcu-
lated as the difference between the instilled volume minus the
drained volume (corrected for sampling volume) divided by
dwell time.
Fig. 2. The volume of dialysis solution instilled into the peritoneal
cavity, drained after the six hour dwell, and the drained + residual (true
volume) at the end of the six hour dwell for the experiments using
FITC-labeled IgG as intravascular tracer. Results are shown using
isotonic dialysis solution (solid bars) and dialysis solution with added
FITC-labeled IgG (cross-hatched bars). Mean values SD are
indicated.
Statistics
All experimental values are expressed as the mean stan-
dard deviation (SD). The dependence of tracer protein concen-
tration in plasma on time was assessed using repeated measures
analysis of variance [191. The significance of differences be-
tween study groups when FITC-labeled IgG was infused into
the bloodstream was assessed by using an unpaired Student's
t-test. The significance of differences between study groups
when DTAF-labeled a-lactalbumin was infused into the blood-
stream was assessed by analysis of variance [20]. Individual
differences between study groups in the latter case were further
analyzed by an unpaired Student's t-test with modified confi-
dence limits computed by the Dunn-Sidák method [20]. Differ-
ences were considered statistically significant at the 0.05 level.
Results
The mean weights of each rabbit group were not different; the
overall mean body weight was 3.1 0.2 kg. During the
experiment each rabbit was conscious, sedated and prone. The
hematocrit was initially 0.38 0.03 and decreased (P < 0.01) to
0.36 0.03 at the end of the six hour dwell.
Measured volumes of dialysis solution in the eight experi-
ments when FITC-labeled IgG was infused into the bloodstream
are shown in Figure 2. The volumes measured did not depend
on whether FITC-labeled IgG was added to the instilled dialysis
solution. The true (drain plus residual) volume at the end of the
six hour exchange was approximately 50% of the initial instilled
volume. The fluid absorption rate was 0.15 0.07 ml/min, a
value somewhat less than but comparable to those previously
reported in the rabbit [21, 22]. Measured volumes of dialysis
solution in the 12 experiments when DTAF-labeled a-lactalbu-
mm was infused into the bloodstream are shown in Figure 3.
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Fig. 3. The volume of dialysis solution instilled into the peritoneal
cavity and the drained + residual (final true volume) at the end of the
six hour dwell for the experiments using DTAF-labeled a-lactalbumin
as intravascular tracer. Results are shown using isotonic dialysis
solution (solid bars), dialysis solution with added DTAF-labeled a-tact-
albumin (cross-hatched bars), and dialysis solution with added FITC-
labeled IgG (dotted bars). Mean values sO are indicated.
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Fig. 4. The dependence of the dialysate-to-plasma fluorescence ratio
on dwell time during the experiments using FITC-labeled IgG as
intravascular tracer. Results are shown using isotonic dialysis solution
(solid squares) and dialysis solution with added FITC-labeled IgG (open
squares). Mean values SD are indicated.
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Fig. 5. The dependence of the dialysate-to-plasma fluorescence ratio
on dwell time during the experiments using DTAF-labeled a-lactalbu-
mm as intravascular tracer. Results are shown using isotonic dialysis
solution (solid squares), dialysis solution with added DTAF-labeled
a-lactalbumin (open squares), and dialysis solution with added FITC-
labeled lgG (asterisks). Mean values SD are indicated.
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These results are similar to those shown in the previous figure
except that the final volumes were somewhat smaller. Corre-
spondingly, the fluid absorption rate for these latter experi-
ments was higher at 0.21 0.04 mI/mm. These results demon-
strate that the addition of trace amounts of protein to the
instilled dialysis solution does not influence rates of fluid
movement into or out of the peritoneal cavity.
Plasma and dialysate fluorescence did not differ from back-
ground levels in the two experiments where no protein tracer
was infused intravenously. When using FITC-labeled IgG and
DTAF-labeled a-lactalbumin as intravascular tracers, plasma
fluorescence was greater than 50 and 25 times background
levels, respectively. Plasma fluorescence decreased continu-
ously with time when FITC-labeled IgG was continuously
infused into the bloodstream (P <0.001), but the total decrease
in fluorescence over the six hour dwell was less than 15%. The
plasma fluorescence when DTAF-labeled a-lactalbumin was
continuously infused into the bloodstream increased by approx-
imately 50% (P < 0.001) during the first two hours of the
exchange, after which the plasma level remained constant.
Thus, plasma concentrations of the protein tracers were rela-
tively constant throughout the experiment.
The dependence of the dialysate to plasma fluorescence ratio
on time is shown in Figure 4 for the experiments where
FITC-labeled IgG was infused intravenously. When protein
tracer was not added to the instilled dialysis solution, fluores-
cence in the dialysis solution increased approximately linearly
with time. At the end of the six hour exchange, the fluorescence
of dialysis solution was still less than 10% of the plasma level.
When FITC-labeled IgG was added to the instilled dialysis
solution, fluorescence in the dialysis solution decreased slightly
during the first hour, after which the increase in fluorescence
was small. Analysis of selected plasma and dialysis solution
samples by size exclusion chromatography demonstrated that
fluorescence was always contained in a single peak. The clear-
ance of FITC-labeled IgG was 14.2 5.5 d/min when no
FITC-labeled IgG was added to the instilled dialysis solution.
The clearance of FITC-labeled lgG decreased (P <0.02) to 3.6
3.5 ,td/min when FITC-labeled IgG was added to the instilled
dialysis solution.
The dependence of the dialysate to plasma fluorescence ratio
on time is shown in Figure 5 for the experiments where
DTAF-labeled a-lactalbumin was infused intravenously. When
protein tracer was not added to the instilled dialysis solution,
fluorescence in the dialysis solution increased approximately
linearly with time. Fluorescence in the dialysis solution after six
hours was greater than 20% of the plasma level; this ratio was
over twice that found when FITC-labeled IgG was the intravas-
cular tracer. When DTAF-labeled a-lactalbumin was added to
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the instilled dialysis solution, fluorescence in the dialysis solu-
tion decreased slightly over the first two hours, after which the
increase in fluorescence was small. When FITC-labeled IgG
was added to the instilled dialysis solution, however, fluores-
cence in the dialysis solution after the first two hours increased
at a rate comparable to that when no protein tracer was added
to the dialysis solution. Again, analysis of selected plasma and
dialysis solution samples by size exclusion chromatography
demonstrated that fluorescence was contained in a single peak.
The clearance of DTAF-labeled a-lactalbumin was 33.2 11.6
.d1min when no tracer protein was added to the instilled dialysis
solution, 11.9 3.4 p1/mm when DTAF-labeled a-lactalbumin
was added to the instilled dialysis solution, and 36.9 10.8
when FITC-labeled IgG was added to the instilled dialysis
solution. These clearances are different (P < 0.01); the value
when DTAF-labeled a-lactalbumin was added to the instilled
dialysis solution was less than the other two values (P <0.05).
Discussion
Previous work has shown that the plasma-to-dialysate trans-
port rate for protein during peritoneal dialysis decreases with
increasing molecular size and that this dependence can be
explained either by combined convection and diffusion across a
heteroporous peritoneal membrane [13] or, alternatively, by
hindered diffusion across the peritoneal membrane [14]. The
present study describes an approach for experimentally differ-
entiating between these contrasting interpretations.
It is important to emphasize that the transport pathway
studied here is not the major route for removal of proteins from
the peritoneal cavity. This latter route has been studied exten-
sively by others [8—12] and involves convective removal of
protein by the lymphatics or directly into tissues surrounding
the peritoneal cavity, When transport occurs by this convective
pathway, however, no net change in protein concentration in
the dialysis solution occurs since protein transport occurs
without sieving at the dialysis solution-tissue interface. Trans-
port by this convective pathway should equal the fluid absorp-
tion rate from the peritoneal cavity, that is, between 150 and 210
p11mm in the present experiments. Indeed, these convective
transport rates are considerably greater than those across the
peritoneal membrane of approximately 35 p1/mm for a-lactal-
bumin and 15 p1/mm for IgG. Therefore, transport by this
convective route is separate from direct plasma to dialysate
transport across the peritoneal membrane. Moreover, the pres-
ence of this significant transport pathway for proteins should
not alter the interpretation of the present experiments.
Clearances determined in the present study when no tracer
protein was added to the instilled dialysis solution can be
compared with previous measurements in the rabbit. Aune [23]
has reported a clearance for radiolabeled human serum albumin
of 92 p1/mm, and Schneider et al [24] have reported a total
protein clearance of 11 p1/mm/kg. Comparison with macromol-
ecules of different chemical composition, such as dextran, must
be made based on equivalent molecular size [14]. Based on
reported diffusion coefficients in free solution of 10.7 X l0—
cm2/sec [17] and 4.0 x l0— cm2/sec [16] for a-lactalburnin and
IgG, respectively, molecular (Stokes) radii of 21 and 55 A were
calculated. Hirszel et al [251 have reported a peritoneal clear-
ance for dextran with the equivalent molecular radius of IgG (55
A) as approximately 5 p1/mm/kg, and Leypoldt et al [26] have
reported a permeability-area product for dextran with the
equivalent molecular radius of a-Iactalbumin (21 A) as approx-
imately 200 p1/mm. When compared with these previous values
measured in the rabbit, therefore, the clearances reported in the
present study are comparable but somewhat low. It is also
possible to compare the clearance for IgG determined in the
present study with corresponding values measured in CAPD
patients by scaling by body weight to the 2/3 power. The
clearance for IgG in the present study would therefore scale to
15 x (70/3)2/3 = 120 jil/min. Compared with previously reported
clearances for IgG in CAPD patients of 56 p1/mm [14], 46 p1/mm
[27], and 90 p1/mm [28], clearances in the present study again
are comparable but appear somewhat high. It should be noted
that the ratio of clearances for a-lactalbumin and IgG of 2.3 is
similar to the ratio of their diffusion coefficients in free solution
(2.7), a relationship that has been pointed out before for
immunoglobulin clearance in CAPD patients [27] and for dex-
tran permeability-area products in the rabbit [26].
Clearance for IgG decreased when IgG was added to the
instilled dialysis solution at 28% of the mean value in plasma.
Thus, plasma to dialysate transport of IgG was significantly
reduced when the difference in IgG concentration across the
peritoneal membrane was decreased, a result suggesting that
convection is not the major mechanism governing IgG transport
across the rabbit peritoneal membrane. In addition, clearance
for a-lactalbumin decreased significantly when cr-lactalbumin
was added to the instilled dialysis solution at 43% of the mean
value in plasma. This result also indicates that plasma to
dialysate transport of a-lactalbumin was reduced when the
difference in a-lactalbumin concentration across the peritoneal
membrane was decreased. Moreover, this decrease in the
a-lactalbumin transperitoneal transport rate was specific for
a-lactalbumin since there was no change in clearance when IgG
was added instead of c-lactalbumin.
The results from the present study can be compared with the
predictions from the recently proposed peritoneal transport
model of Rippe and Stelin [13]. This model predicts that plasma
to dialysate transport of small proteins, such as a-lactalbumin,
across the peritoneal membrane would be governed largely by
diffusion. The results for c-lactalbumin in the present study
confirm this prediction. The model of Rippe and Stelin [13]
predicts, however, that there will be a transition from predom-
inantly diffusive transport to predominantly convective trans-
port as protein size increases. Based on previous data, Rippe
and Stelin have shown that this transition occurs between 44
and 50 A in protein molecular radius. The molecular radius of
IgG (55 A) is larger than this transitional size, and one would
predict that it would therefore behave differently than the small
protein a-lactalbumin. The results for IgG in the present study
do not, however, confirm these predictions but rather suggest
that convection is not the major mechanism governing plasma
to dialysate transport of protein, independent of size, across the
rabbit peritoneal membrane.
A feature of the present experiments for which we have no
explanation is the initial decrease in the dialysate-to-plasma
fluorescence ratio during the first one or two hours in those
exchanges containing tracer protein in the instilled dialysis
solution (Figs. 4 and 5). It is possibly due to either a lag in
mixing of peritoneal contents or, alternatively, to a transient
distribution (diffusion) of protein tracer into tissues surrounding
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the peritoneal cavity. This latter explanation would support the
work of Krediet et al [14], who suggested that there exists an
additional compartment, in addition to plasma and dialysis
solution, that needs to be considered in studies of protein
transport during peritoneal dialysis. Further work to identify
this third compartment appears warranted.
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Appendix
The dependence of tracer protein concentration in the dialysis
solution on time can be predicted from an equation describing protein
transport across the pentoneal membrane coupled to a statement of
protein mass balance for the peritoneal cavity. Two different equations
describe transperitoneal protein transport depending on the assumed
transport mechanism. If diffusion is the predominant mechanism govern-
ing protein transport across the peritoneal membrane, then protein flux i.
into the pentoneal cavity can be described by the following equation
= P(Cb — Cd)
where Cb and Cd denote protein concentrations in plasma and dialysis
solution, respectively, and P denotes peritoneal membrane diffusive
permeability. Alternatively, if the predominant mechanism governing
protein transport is by convection, then J5 is described by
= JVSC
where i denotes the fluid flux into the peritoneal cavity and S denotes
the sieving coefficient for the peritoneal membrane.
Protein mass balance within the peritoneal cavity requires
d(VCd)
dt =J5A—LCd
where V denotes the volume of dialysis solution in the peritoneal
cavity, A denotes the surface area of the peritoneal membrane and L
denotes the fluid absorption rate from the peritoneal cavity by the
lymphatics and directly into tissues surrounding the peritoneal cavity.
When employing isotonic dialysis solution (as in the present experi-
ments), there is limited transperitoneal ultrafiltration; therefore,
changes in dialysate volume are due predominantly to fluid absorption
by the lymphatics and directly into tissues surrounding the peritoneal
cavity. Assuming L is constant, the volume of dialysis solution in the
peritoneal cavity decreases linearly with time according to the following
equation
V = V0 - Lt
where V0 denotes the initial volume of dialysis solution in the peritoneal
cavity. Equation (3) then becomes the following
dCd
V--- = JA
Substituting equations (1) and (4) into equation (5) and solving for Cd
as a function of time yields the following equation valid when diffusion
is the predominant mechanism governing protein transport across the
peritoneal membrane
Cd(t) = Cb + (Cb — Cdo)(l — Lt/V0)"-
Similarly, substituting equations (2) and (4) into equation (5) and solving
for Cd as a function of time yields the alternate equation, valid when
convection is the predominant mechanism governing protein transport
across the pentoneal membrane
Cd(t) = Cdo — (Ci,JvAS/L)log(1 — Lt/V0) (Eq. 7)
where log denotes the natural logarithm.
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